FORA Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,413
Closed -$203K – 631
2024
Q4
$203K Buy
+1,413
New +$203K 0.02% 349
2023
Q1
– Sell
-6,384
Closed -$1.08M – 668
2022
Q4
$1.08M Buy
6,384
+2,471
+63% +$448K 0.17% 154
2022
Q3
$732K Buy
+3,913
New +$825K 0.14% 200
2022
Q2
– Sell
-6,098
Closed -$1.15M – 647
2022
Q1
$1.15M Buy
+6,098
New +$1.16M 0.21% 140
2021
Q4
– Sell
-2,371
Closed -$685K – 436
2021
Q3
$685K Buy
+2,371
New +$608K 0.17% 161
2020
Q4
– Sell
-455
Closed -$67K – 1104
2020
Q3
$67K Buy
+455
New +$65K 0.04% 385

Other funds holding RGEN

FORA Capital's RGEN Position: Q1 2025 in Review

FORA Capital sold out of Repligen (RGEN) in Q1 2025, closing a stake of 1,413 shares — an estimated $203K sold.

FORA Capital first reported a position in RGEN in Q3 2020 and held it in 6 quarters. The position peaked at $1.15M in Q1 2022. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.

  • FORA Capital reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
  • FORA Capital sold 1,413 Repligen shares in Q1 2025, an estimated $203K.
  • FORA Capital first reported a position in Repligen in Q3 2020 and held it in 6 quarters.
  • FORA Capital's Repligen position peaked at $1.15M in Q1 2022.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.

Based on FORA Capital's 13F filing for Q1 2025, filed 14 May 2025.